Lv6
1675 积分 2021-08-06 加入
Concurrent driver mutations in non-small cell lung cancer (NSCLC) patients (p) on targeted therapy uncovered by comprehensive molecular profiling
3个月前
已关闭
Coexistence of driver aberrations in NSCLC patients including ALK/RET/ROS1 rearrangements
3个月前
已关闭
Coexistence of driver aberrations in NSCLC patients including ALK/RET/ROS1 rearrangements
3个月前
已关闭
Concurrent driver mutations in non-small cell lung cancer (NSCLC) patients (p) on targeted therapy uncovered by comprehensive molecular profiling
3个月前
已关闭
皖公网安备34019202002308
